Latest news
Latigo, BlossomHill cap busy week in biotech IPOs with nearly $500M haul - FirstWord PHARMAFirstWord PHARMA · Fri, 07 Aug 2026 17:52:10 GMTCancer drug developer BlossomHill slips post IPO (BLSM:NASDAQ) - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 17:40:23 GMTPain drug developer Latigo rises post-upsized IPO (LTGO:NASDAQ) - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 16:27:44 GMTBlossomHill, Latigo outshine IPO expectations with oversubscribed debuts - Fierce BiotechFierce Biotech · Fri, 07 Aug 2026 15:10:10 GMTStock Market, IPO Leaders Rally To New Highs. Check This Screen Daily. - Investor's Business DailyInvestor's Business Daily · Fri, 07 Aug 2026 13:52:00 GMTLatigo IPO raises nearly $350M for pain drug development - BioPharma DiveBioPharma Dive · Fri, 07 Aug 2026 13:05:46 GMTSK hynix shareholders uneasy over rumored Solidigm Nasdaq listing - Korea JoongAng DailyKorea JoongAng Daily · Fri, 07 Aug 2026 08:55:31 GMTSpaceX lockup expiry to test retail’s iron stomach - ReutersReuters · Thu, 06 Aug 2026 23:30:27 GMT